We are live on
!
Find out more
US Bancorp Portfolio holdings
AUM
$82.4B
1-Year Est. Return
19.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
(+6.6%)
Cap. Flow
-$248M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap ETF
IWR
|
+$45.6M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$40.7M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$38.8M |
| 4 |
iShares S&P 500 Value ETF
IVE
|
+$35.5M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$34.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$80.2M |
| 2 |
Copart
CPRT
|
+$55.9M |
| 3 |
US Bancorp
USB
|
+$47.8M |
| 4 |
IBDK
iShares iBonds Dec 2019 Term Corporate ETF
IBDK
|
+$25.8M |
| 5 |
iShares Floating Rate Bond ETF
FLOT
|
+$17.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.27% |
| 2 | Financials | 10.78% |
| 3 | Industrials | 9.91% |
| 4 | Healthcare | 9.19% |
| 5 | Consumer Staples | 6.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Synchrony
SYF
$23.7B
| $573K | ﹤0.01% |
15,905
-462
| -3% | -$16.5K |
|
1302
LXP Industrial Trust
LXP
$3.53B
| $571K | ﹤0.01% |
10,751
+5,010
| +87% | +$268K |
|
1303
Ormat Technologies
ORA
$6.11B
| $571K | ﹤0.01% |
7,662
-688
| -8% | -$52.1K |
|
1304
InterDigital
IDCC
$6.68B
| $569K | ﹤0.01% |
10,452
-283
| -3% | -$15.6K |
|
1305
Trex
TREX
$4.51B
| $569K | ﹤0.01% |
12,650
+2,262
| +22% | +$99.6K |
|
|
MASI
1306
DELISTED
Masimo
MASI
| $568K | ﹤0.01% |
3,589
-94
| -3% | -$14.1K |
|
1307
Stepan Co
SCL
$1.31B
| $567K | ﹤0.01% |
5,537
| – | – |
|
|
VER
1308
DELISTED
VEREIT, Inc.
VER
| $567K | ﹤0.01% |
12,293
+100
| +0.8% | +$4.79K |
|
|
NUO
1309
DELISTED
Nuveen Ohio Quality Municipal Income Fund
NUO
| $562K | ﹤0.01% |
36,437
+4,814
| +15% | +$75.1K |
|
1310
Seagate
STX
$193B
| $561K | ﹤0.01% |
9,412
+193
| +2% | +$11.1K |
|
|
DOC
1311
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $557K | ﹤0.01% |
29,434
+2,305
| +8% | +$42.3K |
|
|
NEWR
1312
DELISTED
New Relic, Inc.
NEWR
| $556K | ﹤0.01% |
8,462
-1,381
| -14% | -$89.7K |
|
|
GWB
1313
DELISTED
Great Western Bancorp, Inc.
GWB
| $556K | ﹤0.01% |
16,002
+972
| +6% | +$33.6K |
|
1314
Delek US
DK
$3.87B
| $555K | ﹤0.01% |
16,556
+1,578
| +11% | +$56.9K |
|
1315
Assured Guaranty
AGO
$3.78B
| $554K | ﹤0.01% |
11,302
-2,129
| -16% | -$102K |
|
1316
Credit Acceptance
CACC
$6B
| $554K | ﹤0.01% |
1,252
+33
| +3% | +$14.5K |
|
|
PDCO
1317
DELISTED
Patterson Companies, Inc.
PDCO
| $554K | ﹤0.01% |
27,024
-3,620
| -12% | -$68.5K |
|
1318
Banco Santander
SAN
$194B
| $553K | ﹤0.01% |
139,411
-28,371
| -17% | -$110K |
|
1319
Waters Corp
WAT
$36.8B
| $550K | ﹤0.01% |
2,360
+61
| +3% | +$13.5K |
|
|
EVBG
1320
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $550K | ﹤0.01% |
7,041
+2,440
| +53% | +$188K |
|
|
SBNY
1321
DELISTED
Signature Bank
SBNY
| $548K | ﹤0.01% |
4,013
-796
| -17% | -$99.6K |
|
1322
Boise Cascade
BCC
$2.74B
| $547K | ﹤0.01% |
14,997
-1,712
| -10% | -$62.1K |
|
1323
KB Financial Group
KB
$41.2B
| $547K | ﹤0.01% |
13,239
+771
| +6% | +$29.5K |
|
1324
Cable One
CABO
$213M
| $546K | ﹤0.01% |
366
+5
| +1% | +$7.09K |
|
|
AAWW
1325
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $542K | ﹤0.01% |
19,625
-3,848
| -16% | -$96.1K |
|
Similar funds
US Bancorp's Q4 2019 Portfolio in Review
As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.
- US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
- US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
- US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
- US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
- US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
- US Bancorp opened 218 new positions and closed 148 in Q4 2019.
- US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.
Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.